• 1. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

Recent Advances in the Study of 887707-21-3 and (6-Chloro-5-methylpyridin-3-yl)methanol in Chemical Biology and Pharmaceutical Research

The compound 887707-21-3 and its derivative (6-Chloro-5-methylpyridin-3-yl)methanol have garnered significant attention in recent chemical biology and pharmaceutical research due to their potential applications in drug discovery and development. This research brief synthesizes the latest findings on these compounds, focusing on their synthesis, biological activity, and therapeutic potential.

Recent studies have highlighted the role of 887707-21-3 as a key intermediate in the synthesis of various pharmacologically active molecules. Its structural features make it a versatile building block for the development of novel therapeutics. Specifically, (6-Chloro-5-methylpyridin-3-yl)methanol, derived from 887707-21-3, has shown promise in preclinical studies as a potential inhibitor of specific enzymatic pathways implicated in inflammatory and oncogenic processes.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the efficient synthesis of (6-Chloro-5-methylpyridin-3-yl)methanol from 887707-21-3 using a novel catalytic method that improved yield and purity. This advancement is particularly significant for scaling up production for further pharmacological testing. The study also reported preliminary data on the compound's pharmacokinetic properties, suggesting favorable absorption and distribution profiles.

Another important development comes from recent in vitro studies investigating the mechanism of action of (6-Chloro-5-methylpyridin-3-yl)methanol. Research teams at several academic institutions have identified its interaction with specific protein targets involved in cell signaling pathways. These findings, published in Cell Chemical Biology, provide a molecular basis for the compound's observed biological effects and suggest potential therapeutic applications in diseases characterized by dysregulated signaling.

The safety profile of these compounds has also been a focus of recent investigations. Toxicology studies conducted in 2023 indicate that (6-Chloro-5-methylpyridin-3-yl)methanol exhibits a favorable safety window in animal models, with no significant off-target effects observed at therapeutic doses. These results, while preliminary, support further development of this compound as a potential drug candidate.

Looking forward, several research groups have announced plans to explore the therapeutic potential of these compounds in specific disease models. Upcoming clinical trials are expected to evaluate derivatives of 887707-21-3 in inflammatory conditions, while academic-industry partnerships are investigating their application in oncology. The unique chemical properties of these molecules continue to make them attractive targets for medicinal chemistry optimization.

In conclusion, the current research landscape for 887707-21-3 and (6-Chloro-5-methylpyridin-3-yl)methanol demonstrates significant progress in understanding their chemical properties and biological activities. While challenges remain in translating these findings into clinical applications, the accumulating evidence suggests these compounds hold promise for future therapeutic development in multiple disease areas.

• 329794-45-8(2-chloro-3-methyl-4-Pyridinemethanol)
• 111108-62-4(2-chloro-3-(methoxymethyl)pyridine)
• 1205671-57-3(2-chloro-5-ethyl-3-Pyridinemethanol)
• 518314-64-2((2-chloro-5-methylpyridin-3-yl)methanol)
• 42330-59-6((2-chloropyridin-3-yl)methanol)
• 447402-10-0(2-chloro-4-methyl-3-Pyridinemethanol)
• 21543-49-7(2-Chloro-5-hydroxymethylpyridine)
• 125917-60-4((2-CHLORO-3-QUINOLINYL)METHANOL)
• 40508-18-7(6-chloro-3-Pyridinemethanol hydrochloride)
• 55304-90-0((2,6-Dichloropyridin-3-yl)methanol)